Authors
Vikas Yadav, Hussain Beig, Neeru Sangwan, Amit Singh
Published in
The Journal of experimental medicine. Volume 223. Issue 12. Dec 07, 2026. Epub Nov 17, 2026.
Abstract
Mycobacterium tuberculosis (Mtb) persists within the host despite robust immune responses and prolonged multidrug therapy, underscoring the need to better understand the mechanisms that drive persistence and treatment failure. Emerging evidence indicates that redox metabolism is a central interface governing host-pathogen interactions during tuberculosis (TB). This review discusses how redox cross talk integrates immune signaling with bacterial physiology through interconnected pathways involving iron metabolism, lipid peroxidation, mitochondrial bioenergetics, central carbon metabolism, and antioxidant defenses. We highlight how these processes generate physiological, metabolic, and spatial heterogeneity within infected macrophages and granulomas, promoting bacterial persistence, drug tolerance, and tissue pathology. Finally, we discuss therapeutic strategies targeting redox-dependent vulnerabilities in both the host and the pathogen, including modulation of macrophage bioenergetics, nuclear factor erythroid 2-related factor 2 (NRF2) signaling, ferroptosis, and mycobacterial respiration. Integrating host and bacterial redox biology provides a unified framework for developing host-directed and pathogen-directed interventions to improve TB treatment and limit long-term disease sequelae.
PMID:
43043362
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0